Chronic hepatitis B is not curable, but it is treatable. The goal of therapy is to reduce the risk of complications, including premature death. Treatment can help to prevent cirrhosis, liver failure and liver cancer by reducing hepatitis B viral load and the loss of HBeAg (either with or without detection of anti-HBe) while improving liver enzyme levels. Many experts anticipate that medications to cure hepatitis B virus (HBV) will be available, perhaps as early as a few years from now.
Here’s more specific information about each type, or class, of approved HBV treatment along with information about drugs in the late stages of development.
Note: The production of Tyzeka has been discontinued; supplies are available through 2016
